Cancer Research

98 Items

Cancer Research (category from 2022 onwards)

All Items

Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) bench to bedside

Ali Hassanzadeh, Navid Shomali, Amin Kamrani, Mohammad Sadegh Soltani-Zangbar, Hadi Nasiri, Morteza Akbari

862-882
Forkhead Box O (FOXO) signaling in NSCLC pathways to targeted therapies

Lakshmi Thangavelu, Terezinha de Jesus Andreoli Pinto, Sachchidanand Pathak, Abhishek Tiwari, Varsha Tiwari, Gaurav Gupta, Kumud Pant, Saurabh Gupta, Moyad Shahwan

860-861
Notice of retraction "Auraptene-induced cytotoxicity mechanisms in human malignant glioblastoma (U87) cells: role of reactive oxygen species (ROS)"

Seyed Hadi Mousavi

816-817
Exhaled volatile organic compounds in the detection of colorectal cancer a systematic review and meta-analysis

Daniah Alsaadi, Nicolle Clements, Natiya Gabuniya, Nader Francis, Manish Chand

795-810
Molecular pathways and therapeutic strategies in dermatofibrosarcoma protuberans (DFSP) unravelling the tumor’s genetic landscape

Harpreet Singh, Heena Bholaram Choudhary, Deepa Satish Mandlik, Manoj Subhash Magre, Sourav Mohanto, Mohammed Gulzar Ahmed, Bhuvnesh Kumar Singh, Arun Kumar Mishra, Arvind Kumar, Amrita Mishra, T. Venkatachalam, Hitesh Chopra

727-762
Exosomes derived from colorectal cancer cells take part in activation of stromal fibroblasts through regulating PHLPP isoforms

Fatemeh Khaloozadeh, Ehsan Razmara, Fatemeh Asgharpour-Babayian, Alireza Fallah, Reihaneh Ramezani, Fatemeh Rouhollah, Sadegh Babashah

634-654
Ferroptosis and circular RNAs new horizons in cancer therapy

Asif Ahmad Bhat, Neelima Kukreti, Muhammad Afzal, Ahsas Goyal, Riya Thapa, Haider Ali, Moyad Shahwan, Waleed Hassan Almalki, Imran Kazmi, Sami I. Alzarea, Sachin Kumar Singh, Kamal Dua, Gaurav Gupta

570-599
hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma in-silico and in-vitro study

Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Behzad Baradaran

384-400
Overall review of curative impact and barriers of CAR-T cells in osteosarcoma

Guilin Li, Hong Wang, Vafa Meftahpour

364-383
Plasticity and resistance of cancer stem cells as a challenge for innovative anticancer therapies – do we know enough to overcome this?

Agnieszka Knopik-Skrocka, Alicja Sempowicz, Oliwia Piwocka

335-355
Pre-emptive paracetamol reduces intra-operative opioid use in patients undergoing day-case oncologic breast surgery

Daniah Alsaadi, Lyndon Low, James Ting, Michael Craughwell, John McDonnell, Aoife Lowery, Karl Sweeney

356-363
Molecular targeted therapies for cutaneous squamous cell carcinoma recent developments and clinical implications

Harpreet Singh, Hitesh Chopra, Inderbir Singh, Sourav Mohanto, Mohammed Gulzar Ahmed, Shruti Ghumra, Anmol Seelan, Manisha Survase, Arvind Kumar, Amrita Mishra, Arun Kumar Mishra, Mohammad Amjad Kamal

300-334
Diagnostic utility of RAS mutation testing for refining cytologically indeterminate thyroid nodules

Isabel R. Riccio, Alexandra C. LaForteza, Mohammad H. Hussein, Joshua P. Linhuber, Peter P. Issa, Jonathan Staav, Manal Said Fawzy, Eman A. Toraih, Emad Kandil

283-299
Exploring the vast potentials and probable limitations of novel and nanostructured implantable drug delivery systems for cancer treatment

Maryam Ebrahimnia, Sonia Alavi, Hamed Vaezi, Mahdieh Karamat-Iradmousa, Azadeh Haeri

143-179
Empowering personalized medicine unleashing the potential of patient-derived explants in clinical practice

Oliwia Piwocka, Wiktoria M. Suchorska, Katarzyna Kulcenty

81-91
Unraveling NEAT1's complex role in lung cancer biology a comprehensive review

Md Sadique Hussain, Obaid Afzal, Gaurav Gupta, Ahsas Goyal, Waleed Hassan Almalki, Imran Kazmi, Sami I. Alzarea, Abdulmalik Saleh Alfawaz Altamimi, Neelam Kukreti, Amlan Chakraborty, Sachin Kumar Singh, Kamal Dua

34-52
Embelin: A multifaceted anticancer agent with translational potential in targeting tumor progression and metastasis

Adithya Jayaprakash Kamath, Alda Sara Chandy, Aina Ann Joseph, Jaggiah N. Gorantla, Asawari Dilip Donadkar, Lekshmi R. Nath, Javad Sharifi-Rad, Daniela Calina

1311-1329
Potential of melatonin to reverse epigenetic aberrations in oral cancer new findings

Emilio Gil-Martín, Eva Ramos, Francisco López-Muñoz, Javier Egea, Alejandro Romero

1280-1310
Interplay between lncRNA/miRNA and Wnt/β-catenin signaling in brain cancer tumorigenesis

Farzad Rahmani, Abdulridha Mohammed Al-Asady, Reyhane Hanaie, Mehrdad Zandigohar, Homeira Faridnejad, Mahya Payazdan, Pegah Safavi, Mikhail Ryzhikov, Seyed Mahdi Hassanian

1211-1222
In vitro screening of topical formulation excipients for epithelial toxicity in cancerous and non-cancerous cell lines

Farzaneh Forouz , Yousuf Mohammed, Hamid S. A. Shobeiri Nejad , Michael S. Roberts, Jeffrey E. Grice

1173-1199
Bell’s palsy or an aggressive infiltrating basaloid carcinoma post-mRNA vaccination for COVID-19? A case report and review of the literature

Anthony M. Kyriakopoulos, Greg Nigh, Peter A. McCullough, Maria D. Olivier, Stephanie Seneff

992-1011
Bladder cancer course, four genetic high-risk variants, and histopathological findings

Thura Kadhum, Silvia Selinski, Meinolf Blaszkewicz, Jörg Reinders, Emanuel Roth, Frank Volkert, Daniel Ovsiannikov, Oliver Moormann, Holger Gerullis, Dimitri Barski, Thomas Otto, Svetlana Höhne, Jan G. Hengstler, Klaus Golka

867-879
GLUL gene knockdown and restricted glucose level show synergistic inhibitory effect on the luminal subtype breast cancer MCF7 cells’ proliferation and metastasis

Arezu Karimpur Zahmatkesh, Mohammad Khalaj-Kondori, Mohammad Ali Hosseinpour Feizi, Behzad Baradaran

847-861
ctDNA as a novel and promising approach for cancer diagnosis a focus on hepatocellular carcinoma

Negin Biglari, Mohammad Sadegh Soltani-Zangbar, Jamal Mohammadian, Amir Mehdizadeh, Khadijeh Abbasi

752-780
Circular RNAs novel actors of Wnt signaling pathway in lung cancer progression

Mina Alimohammadi, Yasaman Gholinezhad, Vahide Mousavi, Samaneh Kahkesh, Malihe Rezaee, Alireza Yaghoobi, Alireza Mafi, Mahmood Araghi

645-669

Previous 51-75 of 98 Next